Hypoxia: Adaptation Mechanisms and Their Impact on Organs
DOI:
https://doi.org/10.33005/jdiversemedres.v3i3.249Keywords:
hypoxia, HIF pathway, oxidative stress, organ dysfunction, inflammationAbstract
Background: Hypoxia is a decrease in tissue oxygen that induces the activation of hypoxia-inducible factor (HIF) and cellular responses such as metabolic changes, angiogenesis, and inflammatory modulation. This initial adaptive response can become maladaptive with prolonged or repeated exposure.
Methods: This article is a narrative review that examines literature from 2015–2025 from PubMed, ScienceDirect, and Google Scholar. Searches were conducted using keywords related to "hypoxia," "hypoxia-inducible factor (HIF)," "cellular adaptation," and "organ impacts," with selection based on relevance and scientific quality.
Discussion: Hypoxia has various exposure patterns (acute, chronic, and intermittent) that trigger a body response through the activation of oxygen sensors and gene regulation by HIF. In the initial stages, the body attempts to maintain stable cell function. However, prolonged or repeated exposure renders this adaptive response ineffective and leads to tissue disruption. These impacts are seen in various organs, such as changes in heart structure, pulmonary vascular alterations, an increased tendency for fibrosis in the liver and kidneys, and a decreased integrity of the gastrointestinal epithelial barrier, all of which can contribute to disease.
Conclusion: Hypoxia is a complex biological stimulus with dualistic effects that depend on the duration and intensity of exposure. This understanding is crucial for improving diagnostic and therapeutic strategies related to hypoxia.
Keywords: hypoxia, HIF pathway, oxidative stress, organ dysfunction, inflammation
Downloads
References
Mattia M Di, Mauro A, Citeroni MR, Dufrusine B, Peserico A, Russo V, et al. Insight into hypoxia stemness control. Cells. 2021;10(2161):1–45.
Choudhry H, Harris AL. Advances in hypoxia-inducible factor biology. Cell Metab [Internet]. 2018;27:281–98. Available from: https://doi.org/10.1016/j.cmet.2017.10.005
Keeley TP, Mann GE. Defining physiological normoxia for improved translation of cell physiology to animal models and humans. Physiol Rev. 2019;99:161–234.
Chen PS, Chiu WT, Hsu PL, Lin SC, Peng IC, Wang CY, et al. Pathophysiological implications of hypoxia in human diseases. J Biomed Sci. 2020;27(63):1–19.
Wang, Li ZL, Zhang YL, Wen Y, Gao YM, Liu BC. Hypoxia and chronic kidney disease. eBioMedicine [Internet]. 2022;77:1–11. Available from: https://doi.org/10.1016/j.ebiom.2022.103942
Mylonis I, Simos G, Paraskeva E. Hypoxia-inducible factors and the regulation of lipid metabolism. Cells. 2019;8(214):1–16.
Corrado C, Fontana S. Hypoxia and HIF signaling: one axis with divergent effects. Int J Mol Sci. 2020;21(5611):1–17.
Taylor CT, Scholz CC. The effect of HIF on metabolism and immunity. Nat Rev Nephrol. 2022;18(9):573–87.
Kawagoe Y, Sameshima H. Hypoxia: animal experiments and clinical implications. J Obstet Gynaecol Res. 2017;43(9):1381–90.
Liu Q, Palmgren VAC, Danen EH, Le Dévédec SE. Acute vs. chronic vs. intermittent hypoxia in breast cancer: a review on its application in in vitro research. Mol Biol Rep. 2022;49:10961–73.
Millet GP, Burtscher M, Burtscher J. Is hypoxic/altitude training an important topic in the field of hypoxia? J Sci Sport Exerc [Internet]. 2022;4:293–305. Available from: https://doi.org/10.1007/s42978-021-00144-y
Zhu J, Kang J, Li X, Wang M, Shang M, Luo Y, et al. Chronic intermittent hypoxia vs chronic continuous hypoxia: Effects on vascular endothelial function and myocardial contractility. Clin Hemorheol Microcirc. 2020;74(4):417–27.
Hunyor I, Cook KM. Models of intermittent hypoxia and obstructive sleep apnea: molecular pathways and their contribution to cancer. Am J Physiol Regul Integr Comp Physiol. 2018;315:R669–87.
Manninen PH, Unger ZM. Chapter 21 - Hypoxia [Internet]. Complications in Neuroanesthesia. Elsevier Inc.; 2016. 169–180 p. Available from: http://dx.doi.org/10.1016/B978-0-12-804075-1.00021-3
Watts D, Gaete D, Rodriguez D, Hoogewijs D, Rauner M, Sormendi S, et al. Hypoxia pathway proteins are masterregulators of erythropoiesis. Int J Mol Sci. 2020;21(8131):1–18.
Honda T, Hirakawa Y, Nangaku M. The role of oxidative stress and hypoxia in renal disease. Kidney Res Clin Pract. 2019;38(4):414–26.
Kimura W, Nakada Y, Sadek HA. Hypoxia-induced myocardial regeneration. 2017;75390:1676–81.
Senavirathna LK, Hu C, Yang X, Cristina M, Sathiaseelan R, Xu D, et al. Hypoxia induces pulmonary fibroblast proliferation through NFAT signaling. 2018;(February 2017):1–16.
Strowitzki MJ, Ritter AS, Kimmer G, Schneider M. Hypoxia-adaptive pathways : A pharmacological target in fi brotic disease ? 2019;147(July).
Li QY, Liu F, Tang X, Fu H, Mao J. Renoprotective role of hypoxia-inducible factors and the mechanism. Kidney Dis. 2022;8:44–56.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Journal of Diverse Medical Research : Medicosphere
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
